Kids Stuffy Nose And Sinus Tablet
NDC Package 54973-4115-1

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Kids Stuffy Nose And Sinus (oyster shell calcium carbonate, crude, goldenseal, potassium dichromate, pulsatilla pratensis whole) tablets is ■ Use as directed.Children 4 years to under 6 years At onset of symptoms, dissolve 1 tablet under tongue every hour up to 4 hours. This formulation utilizes a tablet delivery system. Marketed by Hyland's Consumer Health Inc., this product is identified by NDC 54973-4115.

Identification & Billing

NDC Package Code
54973-4115-1
Package Description
1 BOTTLE, PLASTIC in 1 CARTON / 50 TABLET in 1 BOTTLE, PLASTIC
Product Code
54973-4115
11-Digit Billing Format
54973411501

Clinical Specifications

Proprietary Name
Kids Stuffy Nose And Sinus
Non-Proprietary Name
Oyster Shell Calcium Carbonate, Crude, Goldenseal, Potassium Dichromate, Pulsatilla Pratensis Whole
Substance Name
Goldenseal; Oyster Shell Calcium Carbonate, Crude; Potassium Dichromate; Pulsatilla Pratensis Whole
Dosage Form
Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Usage Information
■ Use as directed.Children 4 years to under 6 years At onset of symptoms, dissolve 1 tablet under tongue every hour up to 4 hours. If symptoms persist, 1 tablet every 4 hours until relieved. Children 6 years to under 12 years At onset of symptoms, dissolve 2 tablets under tongue every hour up to 4 hours. If symptoms persist, 2 tablets every 4 hours until relieved. Adults and children 12 years and over At onset of symptoms, dissolve 3 tablets under tongue every hour up to 4 hours. If symptoms persist, 3 tablets every 4 hours until relieved.

Regulatory & Marketing

Labeler Name
Hyland's Consumer Health Inc.
Product Type
Human Otc Drug
Marketing Category
UNAPPROVED HOMEOPATHIC - A category specifying that a product is marketed as unapproved homeopathic product.
Start Marketing Date
12-01-2022
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 54973-4115-1 identifies a specific commercial package of 1 bottle, plastic in 1 carton / 50 tablet in 1 bottle, plastic of Kids Stuffy Nose And Sinus, a human over the counter drug labeled by Hyland's Consumer Health Inc.. This tablet is formulated for oral use and contains goldenseal; oyster shell calcium carbonate, crude; potassium dichromate; pulsatilla pratensis whole as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Hyland's Consumer Health Inc. on December 01, 2022. The current certification is valid through December 31, 2026.

How is this Hyland's Consumer Health Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 54973411501. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
54973-4115-1
11-Digit CMS (5-4-2)
54973-4115-01

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.